The following clinical analyses suggested that high EGR1 expression in patients was associated with increased tumor size and advanced TNM staging, and decreased liver function (reflected by increased expression of TBIL, AST and ALT) and LC severity (increased expression of AFP). The gene discussed is EGR1; the disease is neoplasm.